References
<A NAME="RS10905ST-1A">1a</A>
Kojima S.
Inai H.
Hidaka T.
Ohkata K.
J. Soc. Chem., Chem. Commun.
2000,
1795
<A NAME="RS10905ST-1B">1b</A>
Fortin S.
Duppont F.
Deslongchamps P.
J. Org. Chem.
2002,
67:
5437
<A NAME="RS10905ST-1C">1c</A>
Concellón JM.
Bardales E.
J. Org. Chem.
2003,
68:
9492 ; and references therein
<A NAME="RS10905ST-2A">2a</A>
L’Heureux A.
Martel A.
He H.
Chen J.
Sun LQ.
Starrett JE.
Natale J.
Dworetzky SI.
Knox RJ.
Harden DG.
Weaver D.
Thompson MW.
Wu YJ.
Bioorg. Med. Chem. Lett.
2005,
15:
363
<A NAME="RS10905ST-2B">2b</A>
Wickenden AD.
Roeloffs R.
McNaughton-Smith G.
Rigdon GC.
Expert Opin. Ther. Pat.
2004,
14:
1
<A NAME="RS10905ST-2C">2c</A>
Wu Y.-J.
He H.
Sun L.-Q.
L’Heureux A.
Chen J.
Dextraze P.
Starrett JE.
Boissard CG.
Gribkoff VK.
Natale J.
Dworetzky SI.
J. Med. Chem.
2004,
47:
2887
<A NAME="RS10905ST-2D">2d</A>
Wu Y.-J.
Davis CD.
Dworetzky S.
Fitzpatrick WC.
Harden D.
He H.
Knox RJ.
Newton AE.
Philip T.
Polson C.
Sivarao DV.
Sun L.-Q.
Tertyshnikova S.
Weaver D.
Yeola S.
Zoeckler M.
Sinz MW.
J. Med. Chem.
2003,
46:
3778 ; and references therein
<A NAME="RS10905ST-3A">3a</A>
Meth-Cohn O.
Williams DJ.
Chen Y.
J. Chem. Soc., Chem. Commun.
2000,
495
<A NAME="RS10905ST-3B">3b</A>
Meth-Cohn O.
Chen Y.
Tetrahedron Lett.
1999,
40:
6069
<A NAME="RS10905ST-3C">3c</A>
Bremand N.
Marek I.
Normant JF.
Tetrahedron Lett.
1999,
40:
3383
<A NAME="RS10905ST-3D">3d</A>
Kishikawa K.
Furusawa A.
Kohmoto S.
Yamamoto M.
Yamada K.
J. Org. Chem.
1993,
58:
7296
<A NAME="RS10905ST-4A">4a</A>
Braschi I.
Cardillo G.
Tomasini C.
Tetrahedron
1994,
50:
2955
<A NAME="RS10905ST-4B">4b</A>
Cardillo G.
Hashem MA.
Tomasini C.
J. Chem. Soc., Perkin Trans. 1
1990,
1487
<A NAME="RS10905ST-5A">5a</A>
Bell AS.
Fishwick CWG.
Reed JE.
Tetrahedron
1998,
54:
3219
<A NAME="RS10905ST-5B">5b</A>
Bell AS.
Fishwick CWG.
Reed JE.
Tetrahedron Lett.
1996,
37:
123
<A NAME="RS10905ST-6">6</A>
Gotor V.
Menéndez E.
Mouloungui Z.
Gaset A.
J. Chem. Soc., Perkin Trans. 1
1993,
2453
For reviews on the HWE reaction, see:
<A NAME="RS10905ST-7A">7a</A>
Maryanoff BE.
Reitz AB.
Chem. Rev.
1989,
89:
863
<A NAME="RS10905ST-7B">7b</A>
Kelly SE. In
Comprehensive Organic Synthesis
Vol. 1:
Trost BM.
Fleming I.
Pergamon Press;
Oxford:
1991.
p.755
For an asymmetric version of the HWE reaction, see:
<A NAME="RS10905ST-8A">8a</A>
Rein T.
Pedersen TM.
Synthesis
2002,
579
<A NAME="RS10905ST-8B">8b</A>
Rein T.
Reiser O.
Acta Chem. Scand.
1996,
50:
369
For the HWE reaction of chiral phosphonamides, see:
<A NAME="RS10905ST-9A">9a</A>
Pedersen TM.
Jensen JF.
Humble RE.
Rein T.
Tanner D.
Bodmann K.
Reiser O.
Org. Lett.
2000,
2:
535
<A NAME="RS10905ST-9B">9b</A>
Rzasa RM.
Shea HA.
Romo D.
J. Am. Chem. Soc.
1998,
120:
591
<A NAME="RS10905ST-9C">9c</A>
Abiko A.
Masamune S.
Tetrahedron Lett.
1996,
37:
1077
<A NAME="RS10905ST-10">10</A>
Bhattachrya AK.
Thyagarajan G.
Chem. Rev.
1981,
81:
415
<A NAME="RS10905ST-11">11</A>
Ordóñez M.
Hernández-Fernández E.
Xahuentitla J.
Cativiela C.
J. Chem. Soc., Chem. Commun.
2005,
1336
<A NAME="RS10905ST-12">12</A> The non-chiral diethoxyphosphoryl-N-(1-methyl-benzyl)acetamide has been obtained from diethoxyphos-phorylacetyl chloride
and 1-methylbenzylamine and used in the preparation of (E)-N-(1-methylbenzyl)-4-phenyl-2-butenamide via the HWE reaction:
Janecki T.
Bodalski R.
Wieczorek M.
Bujacz G.
Tetrahedron
1995,
51:
1721
<A NAME="RS10905ST-13">13</A>
Blanchette MA.
Choy W.
Davis JT.
Essenfeld AP.
Masamune S.
Roush WR.
Sakai T.
Tetrahedron Lett.
1984,
25:
2183
<A NAME="RS10905ST-14">14</A> Similar HWE reactions using NaI, NaBr, and KI in the presence of DBU have been
reported:
Ando K.
J. Org. Chem.
2000,
65:
4745
<A NAME="RS10905ST-15">15</A>
HWE Reaction Using DBU/LiCl in Anhydrous THF; General Procedure A solution of phosphonamides 2 or 3 (1 equiv) in anhyd THF (30 mL) was treated under nitrogen with DBU (3 equiv) and
LiCl (3 equiv) at r.t. After stirring for 5 min, the aldehyde (1 equiv) was added
and the reaction mixture was stirred for 4 h at r.t. The reaction was quenched by
the addition of a sat. soln of NH4Cl and extracted with EtOAc (3 × 40 mL). The combined extracts were washed with H2O (30 mL) followed by brine (30 mL), dried over Na2SO4, and concentrated. The E/Z ratio was determined by 1H NMR spectroscopy of the crude product, and then the (E)-α,β-unsaturated amides 5a-f and 6a-f were purified by flash chromatography.
(
E
)-(
S
)-
N
-(1-Methylbenzyl)-3-phenylpropenamide 5a Yield: 96%; white solid; mp 146 °C; [α]D -21.7 (c 2.2, CHCl3).
[22]
(
E
)-(
S
)-
N
-(1-Methylbenzyl)-3-(
p
-chlorophenyl)propen-amide (
5b) Yield: 94%; white solid; mp 164-165 °C; [α]D +2.1 (c 2.60, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.53 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 5.24 [quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 6.38 (d, J = 6.8 Hz, 1 H, NH), 6.42 (d, J
trans
= 15.6 Hz, 1 H, =CHCO), 7.24-7.36 (m, 9 H, Harom) 7.55 [d, J
trans
= 15.6 Hz, 1 H, =CH(p-ClC6H4]. 13C NMR (100 MHz, CDCl3): δ = 21.9 [CH3(CH)Ph], 49.2 [CH(CH3)Ph], 121.5, 126.4, 127.6, 128.9, 129.1, 129.2, 133.5, 135.6, 139.9, 143.2, 164.9
(C=O). HRMS (CI+): m/z calcd for C17H17ClNO (MH+): 286.0999; found: 286.0989. Anal. Calcd for C17H16ClNO: C, 71.45; H, 5.64; N, 4.90. Found: C, 71.09; H, 5.60; N, 9.94.
(
E
)-(
S
)-
N
-(1-Methylbenzyl)-3-(
p
-methoxyphenyl)prop-enamide (
5c) Yield: 90%; white solid; mp 149 °C; [α]D +13.2 (c 2.43, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.52 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 3.79 (s, 3 H, CH3O), 5.25 [quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 6.31 (d, J = 6.8 Hz, 1 H, NH), 6.33 (d, J
trans
= 15.6 Hz, 1 H, =CHCO), 6.83 (AA′BB′ system, J = 8.8 Hz, 2 H, Harom), 6.23-6.38 (m, 5 H, Harom), 7.39 (AA′BB′ system, J = 8.8 Hz, 2 H, Harom), 7.58 [d, J
trans
= 15.6 Hz, 1 H, =CH(p-MeOC6H4]. 13C NMR (100 MHz, CDCl3): δ = 21.9 [CH3(CH)Ph], 49.0 [CH(CH3)Ph], 55.5 (CH3O), 114.3, 118.6, 126.4, 127.4, 127.7, 128.8, 129.5, 140.9, 143.4, 160.9, 165.6 (C=O).
HRMS (EI): m/z calcd for C18H19NO2 (M+): 281.1416; found: 281.1408. Anal. Calcd for C18H19NO2: C, 76.84; H, 6.81; N, 4.98. Found: C, 76.88; H, 6.80; N, 5.06.
(
Z
)-(
S
)-
N
-(1-Methylbenzyl)-4-methyl-2-pentenamide (
5d) Yield: 42%; white solid; mp 80-81 °C, [α]D -167 (c 3.13, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 0.94 [d, J = 6.4 Hz, 3 H, (CH3)2CH], 1.00 [d, J = 6.4 Hz, 3 H, (CH3)2CH], 1.50 [d, J = 6.4 Hz, 3 H, CH3(CH)Ph], 3.61-3.70 [m, 1 H, (CH(CH3)2], 5.15 [quint, J = 6.4 Hz, 1 H, CH(CH3)Ph], 5.55 (dd, J
cis
= 11.6 Hz, J
1,4 = 0.8 Hz, 1 H, =CHCO), 5.78 [dd, J
cis
= 11.6 Hz, J
1,3 = 10.0 Hz, 1 H, =CHCH(CH3)2], 5.80 (br, 1 H, NH), 7.22-7.36 (m, 5 H, Harom). 13C NMR (100 MHz, CDCl3): δ = 22.0 [CH3(CH)Ph], 22.8 [2 C, (CH3)2CH], 27.5 [CH(CH3)2], 48.7 [CH(CH3)Ph], 120.0, 126.4, 127.5, 128.8, 143.5, 153.0, 165.7 (C=O). HRMS (EI): m/z calcd for C14H19NO (M+): 217.1467; found 217.1467. Anal. Calcd for C14H19NO: C, 77.38; H, 8.81; N, 6.45. Found: C, 76.88; H, 8.84; N, 6.39.
(
E
)
-
(
S
)-
N
-(1-Methylbenzyl)-4-methyl-2-pentenamide (
5d) Yield: 50%; white solid; mp 94-95 °C, [α]D -123 (c 3.30, CHCl3). 1H NMR (200 MHz, CDCl3): δ = 1.00 [d, J = 7.0 Hz, 3 H, (CH3)2CH], 1.01 [d, J = 7.0 Hz, 3 H, (CH3)2CH], 1.45 [d, J = 7.0 Hz, 3 H, CH3(CH)Ph], 2.33-2.42 [m, 1 H, (CH(CH3)2], 5.17 [quint, J = 7.0 Hz, 1 H, CH(CH3)Ph], 5.80 (dd, J
trans
= 15.6 Hz, J
1,4 = 1.2 Hz, 1 H, =CHCO), 6.62 (br, 1 H, NH), 6.79 [dd, J
trans
= 15.6 Hz, J
1,3 = 6.8 Hz, 1H, =CHCH(CH3)2], 7.21-7.30 (m, 5 H, Harom). 13C NMR (100 MHz, CDCl3): δ = 21.6 [2 C, (CH3)2CH], 21.9 [CH3(CH)Ph], 30.9 [CH(CH3)2], 48.7 [CH(CH3)Ph], 121.0, 126.2, 127.1, 128.5, 143.4, 150.9, 165.5 (C=O). HRMS (EI): m/z calcd for C14H19NO (M+): 217.1467; found: 217.1460. Anal. Calcd for C14H19NO: C, 77.38; H, 8.81; N, 6.45. Found: C, 77.28; H, 8.79; N, 6.38.
(
Z
)-(
S
)-
N
-(1-Methylbenzyl)-5-methyl-2-hexenamide (
5e) Yield: 25%; colorless oil; [α]D -156.9 (c 3.06, CHCl3). 1H NMR (200 MHz, CDCl3): δ = 0.91 [d, J = 6.8 Hz, 3 H, (CH3)2CH], 0.92 [(d, J = 6.8 Hz, 3 H, (CH3)2CH], 1.49 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 1.69 [m, J = 6.8 Hz, 1 H, CH(CH3)2], 2.54 [dddd, J
gem
= 14.6, J
1,3 = 7.4 Hz, J
1,4 = 1.8 Hz, 2 H, CH2CH(CH3)2], 5.15 (quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 5.72 (dt, J
cis
= 11.6 Hz, J
1,4 = 1.8 Hz, 1 H, =CHCO), 5.92 (br, 1 H, NH), 5.99 (dt, J
cis
= 11.6 Hz, J
1,3 = 7.4 Hz, 1 H, =CHCH2
i-Pr), 7.26-7.36 (m, 5 H, Harom). 13C NMR (100 MHz, CDCl3): δ = 22.0 [CH3(CH)Ph], 22.5 [2 C, (CH3)2CH], 28.8 [CH2CH(CH3)2], 37.6 [CH(CH3)2], 48.6 [CH(CH3)Ph], 123.0, 126.4 (C
ortho
), 127.4 (C
para
), 128.8 (C
meta
), 143.5 (C
ipso
), 144.9, 165.9 (C = O). HRMS (EI): m/z calcd for C15H21NO (M+): 231.1623; found: 231.1625.
(
E
)-(
S
)-
N
-(1-Methylbenzyl)-5-methyl-2-hexenamide (
5e) Yield: 67%; white solid; mp 95 °C; [α]D -118.5 (c 2.23, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 0.89 [d, J = 6.8 Hz, 3 H, (CH3)2CH], 0.90 [d, J = 6.8 Hz, 3 H, (CH3)2CH], 1.51 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 1.73 [m, J = 6.8 Hz, 1 H, CH(CH3)2], 2.04 [td, J
1,3 = 7.4 Hz, J
1,4 = 1.4 Hz, 2 H, CH2CH(CH3)2], 5.20 [quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 5.76 (dt, J
trans
= 15.2 Hz, J
1,4 = 1.4 Hz, 1 H, CHC=O), 5.84 (d, J = 6.8 Hz, 1 H, NH), 6.83 [dt, J
trans
= 15.6 Hz, J
1,3 = 7.4 Hz, 1 H, CHCH2CH(CH3)2], 7.24-7.34 (m, 5 H, Harom). 13C NMR (100 MHz, CDCl3): δ = 21.9 [CH3(CH)Ph], 22.7 [2 C, (CH3)2CH], 28.1 [CH2CH(CH3)2], 41.6 [CH(CH3)2], 48.9 [CH(CH3)Ph], 124.6, 126.4, 127.4, 128.8, 143.3, 144.1, 165.1 (C=O). HRMS (EI): m/z calcd for C15H21NO (M+): 231.1623; found: 231.1627. Anal. Calcd for C15H21NO: C, 77.88; H, 9.15; N, 6.05. Found: C, 77.91; H, 9.14; N, 6.15.
(
E
)-(
S
)-
N
-(1-Methylbenzyl)-4,4-dimethyl-2-pentenamide (
5f) Yield: 93%; white solid; mp 94-95 °C; [α]D -120 (c 2.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.05 [s, 9 H, (CH3)3C], 1.51 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 5.21 [quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 5.67 (d, J
trans
= 15.6 Hz, 1 H, =CHCO), 5.92 [d, J = 6.8 Hz, 1 H, NH], 6.85 [d, J
trans
= 15.6 Hz, 1 H, =CHC(CH3)3], 7.25-7.34 (m, 5 H, Harom). 13C NMR (100 MHz, CDCl3): δ = 21.9 [CH3(CH)Ph], 29.1 [(CH3)3C], 33.7 [C(CH3)3], 48.9 [CH(CH3)Ph], 119.0, 126.5, 127.6, 128.9, 143.5, 155.1, 165.7 (C=O). HRMS (EI): m/z calcd for C15H21NO (M+): 231.1623; found: 231.1635. Anal. Calcd for C15H21NO: C, 77.88; H, 9.15; N, 6.05. Found: C, 77.76; H, 9.08; N, 6.12.
(E
)-(
S
)-
N
-(1-Methylbenzyl)-2-methyl-3-phenyl-propenamide (
6a) Yield: 90%; white solid; mp 113-114 °C; [α]D -4.0 (c 1.94, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.57 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 2.08 (d, J = 1.6 Hz, 3 H, CH3C=CH), 5.25 [quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 6.21 (d, J = 6.8 Hz, 1 H, NH), 7.25-7.39 (m, 11 H, 10 × Harom, Hvinyl). 13C NMR (100 MHz, CDCl3): δ = 14.6 (CH3C=CH), 21.9 [CH3(CH)Ph], 49.3 [CH(CH3)Ph], 126.4, 127.5, 127.9, 128.4, 128.8, 129.4, 132.1, 134.0, 136.2, 143.3, 168.7
(C=O). HRMS (CI+, CH4): m/z calcd for C18H19NO (M+): 265.1466; found: 265.1479. Anal. Calcd for C18H19NO: C, 81.47; H, 7.22; N, 5.28. Found: C, 81.56; H, 7.22; N, 5.38.
(
E
)-(
S
)-
N
-(1-Methylbenzyl)-2-methyl-3-(
p
-chloro-phenyl)propenamide (
6b) Yield: 96%; white solid; mp 118-119 °C; [α]D +5.9 (c 2.34, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.57 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 2.06 (d, J = 1.2 Hz, 3 H, CH3C=CH), 5.24 [quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 6.18 (d, J = 6.8 Hz, 1 H, NH), 7.23 (AA′BB′ system, J = 8.4 Hz, 2 H, Harom), 7.26-7.37 (m, 8 H, 7 × Harom, Hvinyl). 13C NMR (100 MHz, CDCl3): δ = 14.6 (CH3C=CH), 21.9 [CH3(CH)Ph], 49.4 [CH(CH3)Ph], 126.3, 127.5, 128.7, 128.8, 130.7, 132.7, 132.8, 133.7, 134.6, 143.2, 168.4
(C=O). HRMS (CI+, CH4): m/z calcd for C18H19ClNO (MH+): 300.1155; found: 300.1146. Anal. Calcd for C18H18ClNO: C, 72.11; H, 6.05; N, 4.67. Found: C, 71.89; H, 6.07; N, 4.83.
(
E
)-(
S
)-
N
-(1-Methylbenzyl)-2-methyl-3-(
p
-methoxy-phenyl)propenamide (
6c) Yield: 86%; white solid; mp 117-118 °C; [α]D +14.8 (c 2.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.56 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 2.09 (d, J = 1.2 Hz, 3 H, CH3C=CH), 3.81 (s, 3 H, CH3O), 5.24 [quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 6.16 (d, J = 6.8 Hz, 1 H, NH), 6.89 (AA′BB′ system, J = 8.4 Hz, 2 H, Harom), 7.28 (AA′BB′ system, J = 8.4 Hz, 2 H, Harom), 7.29-7.39 (m, 6 H, 5 × Harom, Hvinyl). 13C NMR (100 MHz, CDCl3): δ = 14.5 (CH3C=CH), 21.9 [CH3(CH)Ph], 49.3 [CH(CH3)Ph], 55.5 (CH3O), 114.0, 126.5, 127.5, 128.9, 129.0, 130.5, 131.1, 133.7, 143.6, 159.5, 169.1 (C=O).
HRMS (CI+, CH4): m/z calcd for C19H22NO2 (MH+): 296.1651; found: 296.1653. Anal. Calcd for C19H21NO2: C, 77.26; H, 7.17; N, 4.74. Found: C, 77.40; H, 7.23; N, 4.91.
<A NAME="RS10905ST-16">16</A>
The E and Z isomers for 5d and 5e were easily separable by flash chromatography.
<A NAME="RS10905ST-17">17</A>
When the minor diastereomer was not detected, an E/Z ratio 98:02 is shown in Tables
[1]
and
[3]
.
<A NAME="RS10905ST-18">18</A>
The coupling constant between the olefinic protons of compound 5a-f was J = 15 Hz for E and J = 11 Hz for Z; this is in agreement with the average literature values.
<A NAME="RS10905ST-19">19</A>
Sano S.
Takemoto Y.
Nagao Y.
Arkivoc
2003,
(viii):
93
<A NAME="RS10905ST-20">20</A>
Thompson SK.
Heathcock CH.
J. Org. Chem.
1990,
55:
3386
Phosphonamides bearing amino acids have been used in the HWE reaction:
<A NAME="RS10905ST-21A">21a</A>
Ordóñez, M.; Bustos-Salgado, P.; Bautista-de la Cruz, R.; Hernández-Fernández, E.;
Rojas-Cabrera, H. manuscript in preparation
<A NAME="RS10905ST-21B">21b</A>
Coutrot Ph.
Grison C.
Gérardin-Charbonnier C.
Lecouvey M.
Tetrahedron Lett.
1993,
34:
2767
<A NAME="RS10905ST-22">22</A> For the R enantiomer: mp 144-146 °C, [α]D +20.2 (c 1.0, CHCl3), see:
Gotor V.
Menéndez E.
Mouloungui Z.
Gaset A.
J. Chem. Soc., Perkin Trans. 1
1993,
2453